Federation Bio is pioneering new platforms that target diseases in which the human microbiome can play a curative role. The company’s microbial approach leverages naturally occurring bacteria along with a diverse community of supportive bacteria to drive engraftment and durable therapeutic responses. This approach has potential in a diverse set of human conditions ranging from metabolic disorders and cholestatic diseases to cancer and autoimmune conditions. Federation Bio’s lead program is in secondary hyperoxaluria, a serious renal condition that affects more than 200,000 Americans and for which there are currently no approved therapies. Additional information can be found at www.federation.bio
Location: United States, California, South San Francisco
Member count: 11-50
Total raised: $50M
Founded date: 2019
Investors 1
Date | Name | Website |
- | Altitude L... | altitudels... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
06.10.2020 | Series A | $50M | - | prnewswire... |
Mentions in press and media 5
Date | Title | Description | Source |
08.01.2021 | Venrock’s Bryan Roberts on the firm’s new $450 million fund,... | Venrock, the 51-year-old firm that started as the venture arm of the Rockefeller family, has closed ... | techcrunch... |
09.10.2020 | Microbial Therapy Company Federation Bio Raises $50 Million | Federation Bio — a microbial therapeutics company targeting diseases in which the human microbiome c... | pulse2.com... |
07.10.2020 | Federation Bio Raises $50M in Series A Financing | Federation Bio, a South San Francisco, CA-based microbial therapeutics company targeting diseases in... | finsmes.co... |
06.10.2020 | Federation Bio Launches with $50 Million Series A Financing ... | SOUTH SAN FRANCISCO, Calif., Oct. 6, 2020 /PRNewswire/ -- Federation Bio, a microbial therapeutics... | prnewswire... |
06.10.2020 | The Crunchbase News Briefing: Tue., Oct. 6 | 5 Shares Email Facebook Twitter LinkedIn Here’s what you need to know today in startup and venture ... | news.crunc... |